
Anup Kasi MD MPH
@anup_kasi
GI medical oncologist and researcher @ Univ of Kansas
ID: 939338754715766785
09-12-2017 03:39:46
509 Tweet
1,1K Takipçi
570 Takip Edilen




🎉 Wow, congrats to my amazing mentee for his work on evaluating real-world results of PRRT in GEP-NETs! The significant findings for a unique patient subset are intriguing . So proud to be your mentor, Stijn Hentzen, MD ! 🙌 NET Research Foundation #NETCancer #Carcinoid #GEPNETs #NETsResearch

Excellent session on GI Cancers with Joleen Hubbard, Robert McWilliams (Mayo Clinic), and Anup Kasi MD MPH (The University of Kansas Health System) followed by an engaging Q&A discussion! Very important updates at #BestofASCO in Minneapolis, MN!


Thank you Binay Shah, MD, MHA for the invitation to speak on Upper GI cancers. It was an absolute delight to present at the impeccably organized educational conference #BestOfASCO Beyond Trauma Foundation KU Cancer Center

Had an amazing experience at #GDUGI2023! Engaging in stimulating debate-style discussions was a privilege. Huge thanks to Dr. Cathy Eng and Great Debates for the invitation to share my thoughts! 🗣️🙌


At the 20th #ISGO PER, Eileen M O’Reilly from Memorial Sloan Kettering Cancer Center gave an insightful kickoff presentation on pancreatic cancer #PDAC. Exciting developments on #KRAS targeted therapy for 2023 and beyond. Anup Kasi MD MPH Tanios Bekaii-Saab, MD



Pancreatic cancer moving the needle on improved outcomes, every bit counts for these patients. With 5 year OS of 13%, more studies needed. NAPOLI3 trial for journal club today with Anup Kasi MD MPH @smullangiMd #PancreaticCancer #JournalClub


#ASCO24 - At 1:30 pm, head over to Hall A where Anup Kasi MD MPH and the @KUCancerCenter team are presenting “Association of circulating DNA with recurrence in CRS-HIPEC patients with colorectal and appendiceal peritoneal carcinomatosis: Insights from a phase II randomized trial.”


🏁 Excited to share the news that we have completed full enrollment of #PancreaticCancer Cohort of our CENDIFOX Trial - goo.gl/alerts/4TU3F1 Lisata Therapeutics, Inc. KU Cancer Center KU Hospital News PanCAN Let's Win Pancreatic Cancer 💜 #PancSM Chat Looking forward to the results in the near future !

Thank you Binay Shah, MD, MHA for inviting me to discuss #Hepatobiliary and #pancreaticcancer updates from #ASCO24. It was an honor to present at such a well-organized and educational conference. #BestOfASCO @asco2024 Beyond Trauma Foundation #globaloncology KU Cancer Center


Thrilled to speak at the #KUICE_T symposium on the role of #CAR_T in solid tumors! Huge thanks to Al-Ola A Abdallah MD (USMIRC) & Nausheen Ahmed MD for the invitation. The event was incredibly insightful, showcasing the latest in cellular therapeutics for hematology and oncology! KU Cancer Center




When a UPMC Hillman Cancer Center Pittsburgh investigator escaped from the East Coast to reconnect with her KU Cancer Center Kansas roots in the heart of the Midwest! SWOG Cancer Research Network #MidwestMagic at Chicago


Distinct molecular and clinical features of KRAS G12 mutations in Pancreatic Cancer oncodaily.com/url/228259 Jash Datta, MD Clinical Cancer Research Anup Kasi MD MPH Emil Lou, MD, PhD, FACP Rachna Shroff, MD, MS, FASCO Mike Pishvaian #Cancer #GIOnc #Pancsm #MedEd #MedX #MedNews #Health #Medicine #OncoDaily #Oncology